OPi Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

OPi General Information

Description

Operator of a bio-pharmaceutical company in France. The company engages in developing and marketing therapeutic agents and monoclonal antibodies for treating rare and severe diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Les Jardins d'Eole
  • 3 allée des Séquoias
  • 69760 Limonest
  • France
+33 04
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • Les Jardins d'Eole
  • 3 allée des Séquoias
  • 69760 Limonest
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OPi Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OPi‘s full profile, request access.

Request a free trial

OPi Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OPi‘s full profile, request access.

Request a free trial

OPi Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Snc Picot Angers Paris, France 1987

OPi FAQs

  • When was OPi founded?

    OPi was founded in 1999.

  • Where is OPi headquartered?

    OPi is headquartered in Limonest, France.

  • What industry is OPi in?

    OPi’s primary industry is Biotechnology.

  • Is OPi a private or public company?

    OPi is a Private company.

  • What is OPi’s current revenue?

    The current revenue for OPi is .

  • How much funding has OPi raised over time?

    OPi has raised $13.4M.

  • Who are OPi’s investors?

    BioMérieux, Caisse des Depots Group, Innoveris, Rhône-Alpes Création, and Seventure are 5 of 7 investors who have invested in OPi.

  • When was OPi acquired?

    OPi was acquired on 22-Mar-2007.

  • Who acquired OPi?

    OPi was acquired by EUSA Pharma (UK).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process